70 related articles for article (PubMed ID: 27417252)
1. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer.
Chen S; Liu Z; Wu H; Wang B; Ouyang Y; Liu J; Zheng X; Zhang H; Li X; Feng X; Li Y; Shen Y; Zhang H; Xiao B; Yu C; Deng W
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426604
[TBL] [Abstract][Full Text] [Related]
4. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis.
Duan W; Liu W; Xia S; Zhou Y; Tang M; Xu M; Lin M; Li X; Wang Q
J Transl Med; 2023 Aug; 21(1):547. PubMed ID: 37587486
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Gallego O; Ruiz FX; Ardèvol A; Domínguez M; Alvarez R; de Lera AR; Rovira C; Farrés J; Fita I; Parés X
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20764-9. PubMed ID: 18087047
[TBL] [Abstract][Full Text] [Related]
6. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
J Ethnopharmacol; 2024 May; 332():118354. PubMed ID: 38762210
[TBL] [Abstract][Full Text] [Related]
7. The Role of AKR1B10 in Physiology and Pathophysiology.
Endo S; Matsunaga T; Nishinaka T
Metabolites; 2021 May; 11(6):. PubMed ID: 34063865
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma physiology and pathology in gastrointestinal epithelial cells.
Thompson EA
Mol Cells; 2007 Oct; 24(2):167-76. PubMed ID: 17978568
[TBL] [Abstract][Full Text] [Related]
9. CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10.
Kong D; Wu Y; Tong B; Liang Y; Xu F; Chi X; Ni L; Tian G; Zhang G; Xu Z
Biochim Biophys Acta Mol Basis Dis; 2024 May; 1870(6):167214. PubMed ID: 38718846
[TBL] [Abstract][Full Text] [Related]
10. Pd
Carneiro TJ; Batista de Carvalho ALM; Vojtek M; Laginha RC; Marques MPM; Diniz C; Gil AM
J Med Chem; 2024 Apr; 67(8):6839-6853. PubMed ID: 38590144
[TBL] [Abstract][Full Text] [Related]
11. Role of AKR1B10 in inflammatory diseases.
Guo M; Wang T; Ge W; Ren C; Ko BC; Zeng X; Cao D
Scand J Immunol; 2024 May; ():e13390. PubMed ID: 38769661
[TBL] [Abstract][Full Text] [Related]
12. Effects of ligand binding on the stability of aldo-keto reductases: Implications for stabilizer or destabilizer chaperones.
Kabir A; Honda RP; Kamatari YO; Endo S; Fukuoka M; Kuwata K
Protein Sci; 2016 Dec; 25(12):2132-2141. PubMed ID: 27595938
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.
Reddy KA; Kumar PU; Srinivasulu M; Triveni B; Sharada K; Ismail A; Reddy GB
Breast; 2017 Feb; 31():137-143. PubMed ID: 27855345
[TBL] [Abstract][Full Text] [Related]
14. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of aldo‑keto reductase family 1 member B10 in human nasopharyngeal carcinoma.
Lu J; Kang T; Zhang Z
Mol Clin Oncol; 2023 Nov; 19(5):89. PubMed ID: 37854325
[TBL] [Abstract][Full Text] [Related]
16. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
Yao H; Hu J; Shao Y; Shah Q; Zheng S
Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
[TBL] [Abstract][Full Text] [Related]
17. Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation.
Wang H; Zhang J; Liu J; Jiang Y; Fu L; Peng S
Front Mol Biosci; 2023; 10():1124956. PubMed ID: 36845547
[No Abstract] [Full Text] [Related]
18. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer.
Hojnik M; Šuster NK; Smrkolj Š; Sisinger D; Grazio SF; Verdenik I; Rižner TL
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159076
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
